Holiferm Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $23M

  • Investors
  • 10

Holiferm General Information

Description

Developer of fermentation technology and processes designed to deliver environmentally friendly biosurfactant products. The company's technology uses gravity separation to recover insoluble lipids as they are produced by fermentation, enabling businesses to get an environmentally friendly alternative to traditional surfactants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Units 7-14, Ocean Park
  • Dock Road, Wirral
  • Birkenhead CH41 1HW
  • England, United Kingdom
Primary Industry
Specialty Chemicals
Vertical(s)
Corporate Office
  • Units 7-14, Ocean Park
  • Dock Road, Wirral
  • Birkenhead CH41 1HW
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Holiferm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series B) 18-Sep-2023 $23M Completed Generating Revenue
13. Early Stage VC 27-Sep-2022 Completed Generating Revenue
12. Grant 01-Jan-2022 Completed Generating Revenue
11. Early Stage VC 12-Nov-2021 Completed Generating Revenue
10. Grant 09-Nov-2020 Completed Generating Revenue
9. Grant 01-Nov-2020 Completed Generating Revenue
8. Grant 01-Jun-2020 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
6. Grant 01-Jul-2019 $265K $1.3M Completed Generating Revenue
5. Early Stage VC (Series A) 01-May-2019 $1.3M $1.3M Completed Generating Revenue
To view Holiferm’s complete valuation and funding history, request access »

Holiferm Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B Preferred
Series A-1 Preferred
Series A
Preferred Ordinary
Preferred Ordinary 3,213 $0.001257 $146.68 $146.68 1x $146.68 3.3%
Preferred Ordinary 4,286 $0.001257 $146.61 $146.61 1x $146.61 4.41%
To view Holiferm’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Holiferm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Holiferm Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clean Growth Fund Impact Investing Minority
Rhapsody Venture Partners Venture Capital Minority
I2F2 Other
Enterprise Hub - Royal Academy of Engineering Accelerator/Incubator Minority
Innovate UK Government
You’re viewing 5 of 10 investors. Get the full list »

Holiferm Acquisitions (2)

Holiferm’s most recent deal was a Merger/Acquisition with Alzo International. The deal was made on 11-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alzo International 11-Sep-2026 Merger/Acquisition Specialty Chemicals
Organica (UK) 08-Sep-2026 Merger/Acquisition Household Products
To view Holiferm’s complete acquisitions history, request access »

Holiferm Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Holiferm Manufacturing Birkenhead, United Kingdom 2021
Organica (UK) Birkenhead, United Kingdom 1998
Alzo International Sayreville, NJ 1975

Holiferm FAQs

  • When was Holiferm founded?

    Holiferm was founded in 2018.

  • Where is Holiferm headquartered?

    Holiferm is headquartered in Birkenhead, United Kingdom.

  • What is the size of Holiferm?

    Holiferm has 60 total employees.

  • What industry is Holiferm in?

    Holiferm’s primary industry is Specialty Chemicals.

  • Is Holiferm a private or public company?

    Holiferm is a Private company.

  • What is the current valuation of Holiferm?

    The current valuation of Holiferm is .

  • What is Holiferm’s current revenue?

    The current revenue for Holiferm is .

  • How much funding has Holiferm raised over time?

    Holiferm has raised $37.7M.

  • Who are Holiferm’s investors?

    Clean Growth Fund, Rhapsody Venture Partners, I2F2, Enterprise Hub - Royal Academy of Engineering, and Innovate UK are 5 of 10 investors who have invested in Holiferm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process